Skip to main content

Table 1 Co-effect of SAHA and veliparib

From: PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells

Cell lines (SAHA: Veliparib)

CI values (IC50)

LNCap (1:20)

0.86

C4–2 (1:20)

0.95

VCaP (1:20)

0.90

CWR22Rv1 (1:20)

0.85

PC-3 (1:20)

0.74

DU145 (1:20)

0.85

RWPE-1 (1:20)

1.05

  1. IC50: Half maximal inhibitory concentration
  2. CI value: Combination index value
  3. CI < 1 indicates synergy; CI = 1 indicates addictivity; CI > indicates antagonism